Working… Menu

A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03022175
Recruitment Status : Completed
First Posted : January 16, 2017
Last Update Posted : October 5, 2017
CPR Pharma Services Pty Ltd, Australia
Information provided by (Responsible Party):
Spero Therapeutics